R Squared LTD Cardiff Oncology, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, R Squared LTD holds 290 shares of CRDF stock, worth $1,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
290Holding current value
$1,165% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRDF
# of Institutions
92Shares Held
12.2MCall Options Held
813KPut Options Held
91.1K-
Black Rock Inc. New York, NY2.63MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$8.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA928KShares$3.73 Million0.0% of portfolio
-
State Street Corp Boston, MA833KShares$3.35 Million0.0% of portfolio
-
Mai Capital Management663KShares$2.67 Million0.02% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $174M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...